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Methods: We reviewed the clinical data of all patients
diagnosed with primary angiosarcoma of the heart, aorta,
and great vessels from 1985 to 2011, including presenta-
tion, diagnosis, management, and outcomes.
Results: Thirteen patients (5 males and 8 females;
mean age, 544 years) had primary angiosarcoma arising
from the aorta (n7), heart (n3), pericardium (n2),
and pulmonary artery (n1). Aortic tumors most com-
monly presented with lower extremity claudication (n4),
renovascular HTN (n3), abdominal pain (n5), and
weight loss (n4). Cardiac and pericardial tumors pre-
sented with dyspnea (n5) due to pleural effusion or
cardiac tamponade. All 13 patients underwent Com-
puted Tomography (CT) scan demonstrating irregular,
lobulated mass/thrombus with peripheral enhancement
and 8 patients had diagnostic echocardiogram. Meta-
static disease was present in 10 patients; most common
site was lungs (n6). All except one patient had high
grade sarcoma on pathology. Most common endothelial
antigen was CD31. Nine patients were treated surgically;
resection with aortic reconstruction (n6), thrombec-
tomy (n1), and pericardiectomy with patch (n2).
Adjunctive treatment included chemotherapy (n7) and
radiation (n4). Median survival was 8 months (range
1-75). Patients treated with all 3 treatment modalities
had longer survival than patients treated with a single
modality (P.013). Patients treated with chemotherapy
had a more favorable survival than those without chemo-
therapy (P.048).
Conclusions: Primary angiosarcoma of the heart and
great vessels is rare, but a harbinger of poor prognosis.
Endothelial antigen CD31 is diagnostic. Combined ther-
apy with surgical resection and chemoradiotherapy offer
patients the best survival.
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Objectives: To examine the outcomes of tibial endo-
vascular interventions with respect to ulcer healing and
prevention of major limb loss.
Methods: A database of patients between 2001 and
2011 was queried. Patients presenting with tissue loss
(Rutherford class 5 and 6) were selected. Immediate suc-
cess of the intervention was defined as healing of the
ulcer or a successful forefoot amputation after interven-
tion. Clinical efficacy was defined as absence of recurrent
symptoms, maintenance of ambulation and absence of
major amputation.
Results: : 248 limbs in 245 patients (60% male, mean
age 67) underwent tibial artery interventions for tissue loss.
68% had diabetes, 63% hyperlipidemia and 24% chronic
renal insufficiency. The mean patent tibial vessels at presen-
tation were 1.20.6 (SD). 76% of the tibial lesions were
TASC C. Technical success was 98% with a mean of 2
vessels treated per patient. 388 tibials were treated. Overall
mortality was 1% and overall morbidity was 14% at 90 days
after the procedure. 76% of ulcers healed after the interven-
tion at a mean of 9 months. 34% required either toe or
trans-metatarsal amputation, while 24% of the limbs under-
went major amputation. Cumulative patency was 685% at
five years. 31% of patients necessitated two or more re-
interventions. At 5 years, freedom from ulcer recurrence
and major limb amputations were 544% and 486%,
respectively. Clinical efficacy was 344% at 5 years. OnCox
proportional hazard analysis, greater tissue loss at presen-
tation, BMI30, diabetes, hemodialysis, low mobility at
presentation, higher tibial TASC lesion and poor pedal
runoff were associated with decreased ulcer healing and
lower limb salvage.
Conclusions: Tibial interventions do allow for ulcer
healing within one year with a lowmortality andmorbidity;
however, one in four patients will require a major amputa-
tion within 5 years.
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Objectives: Evaluate whether closure devices (CD) are
a safe method for preventing surgical complications associ-
ated with femoral access. As a secondary goal, the use of
ultrasound for femoral access and performance of an ade-
quate completion angiogram prior to CD deployment were
evaluated.
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Methods: All patients at a tertiary care facility that
underwent femoral arterial access from January 2009 to
July 2011 were reviewed. Arterial complications that re-
sulted in operative repair during hospitalization were iden-
tified. Cases were separated into those utilizing CD and
those employing manual compression (MC). The two
groups were evaluated for demographic and procedural
differences. The subgroup of patients that underwent CD
placement were then evaluated for ultrasound use and
performance of adequate completion angiogram.
Results: 11,114 cases were reviewed. CD were
placed in 5576 (50.2%) while MC was used in 5538
(49.8%%). Surgical complications were identified in 30
(0.54%) of CD cases and 26 (0.47%) of MC cas-
es(P.61). Demographic data and procedural data was
not statistically significant between the two groups ex-
cept for younger average age in the CD subset (P.032).
Amongst the 30 surgical complications employing CD, 7
patients (23.3%) were found to have access in the wrong
vessel. Ultrasound was utilized in 4/30 cases (13.3%).
Completion angiograms were not recorded in 12/30
(40%) of cases. In 11/18 cases (61%) completion angio-
grams were determined to be inadequate for placement
of a CD.
Conclusions:Our data suggests that use of CD follow-
ing femoral artery access does not decrease the rate of
surgical complications compared with MC. Demographic
and procedural factors did not appear to influence the
complication rate. In 10/30 (33.3%) cases the wrong vessel
was accessed or a device was deployed in an inadequate
vessel by completion angiography. Unless, factors can be
employed to decrease the rate of complications, we cannot
justify the use of CD in the prevention of surgical
complications.
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Objectives: We report our experience with the use of a
novel Thermo-Sensitive Polymer (LeGoo) for distal vessel
control during Infra-Popliteal Bypasses (IPB) in patients
with severe leg ischemia.
Methods: Retrospective analysis of all IPB procedures
performed using LeGoo from January 2010 till April 2011.
We specifically looked at technical success in achieving
bloodless anastomotic field, intraoperative LeGoo-related
complication and re-intervention for anastomosis-related
lesion during follow-up.
Results: Thirty-four IPBs using LeGoo were per-
formed during the study period. The distal anastomosis was
performed to the Anterior tibial artery (n.9), Posterior
tibial artery (n.7), Peroneal artery (n.5), Tibio-Per-
oneal trunt (n.6) and Dorsalis Pedis artery (n.7). Fol-
low-up period ranged from 4 to 24 months. They were all
enrolled in a duplex graft surveillance programme and were
offered intervention for threatened grafts. Twenty-three
patients completed at least 1 year follow-up. Bloodless
anastomotic field was achieved in 32 patients. One patient
needed a Fogarty catheter-assisted retrieval of the occlusive
polymer plug for the outflow vessel. Five patients needed
salvage angioplasty, 2 of them for a distal anastomosis-
related stenosis. Four grafts occluded during follow-up,
one was successfully thrombolysed and 2 patients had a
major amputation.
Conclusions: LeGoo is a potentially safe and useful
device to achieve a bloodless distal anastomotic filed in
patients undergoing IPBs. This may be particularly impor-
tant in constructing the anastomosis to a calcified distal
vessel. A large randomised controlled study is needed to
support our findings.
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